Literature DB >> 21390153

HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study.

Hai-Bo Qiu1, Li-Yi Zhang, Zhao-Lei Zeng, Zhi-Qiang Wang, Hui-Yan Luo, Rajiv Prasad Keshari, Zhi-Wei Zhou, Rui-Hua Xu.   

Abstract

AIM: To evaluate the effect of hepatitis B virus (HBV) infection on liver metastasis of colorectal cancer.
METHODS: A total of 1298 colorectal cancer patients were recruited from January 2001 to March 2005 in this study. Enzyme-linked immunosorbent assay was used to test serum HBV markers for colorectal cancer. Patients were divided into study (infection) group and control (non-infection) group. Clinical features of patients in two groups were compared.
RESULTS: Liver metastasis was found in 319 out of the 1298 colorectal cancer patients. The incidence of liver metastasis was significantly lower in study group than in control group (14.2% vs 28.2%, P < 0.01). HBV infection significantly decreased the risk of liver metastasis [hazard ratio (HR): 0.50, 95% confidence interval (95% CI): 0.38-0.66], but the incidence of extrahepatic metastasis was significantly higher in study group than in control group (31.9% vs 17.0%, P < 0.01). The HR was the lowest in chronic hepatitis B group (HR: 0.29, 95% CI: 0.12-0.72). The number of liver metastatic lesions was significantly less in study group than in control group with a higher surgical resection rate. However, no significant difference was found in survival rate between the two groups (P = 0.95).
CONCLUSION: HBV infection decreases the risk of liver metastasis in patients with colorectal cancer and elevates the surgical resection rate of liver metastatic lesions.

Entities:  

Keywords:  Colorectal cancer; Hepatitis B virus; Liver metastasis; Risk

Mesh:

Substances:

Year:  2011        PMID: 21390153      PMCID: PMC3042661          DOI: 10.3748/wjg.v17.i6.804

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.

Authors:  D G Doherty; S Norris; L Madrigal-Estebas; G McEntee; O Traynor; J E Hegarty; C O'Farrelly
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

2.  Perforin and granzyme B lytic protein expression during chronic viral and autoimmune hepatitis.

Authors:  T Tordjmann; A Soulie; C Guettier; M Schmidt; C Berthou; M Beaugrand; M Sasportes
Journal:  Liver       Date:  1998-12

Review 3.  Treatment of metastatic disease of the liver: a skeptic's view.

Authors:  J H Foster
Journal:  Semin Liver Dis       Date:  1984-05       Impact factor: 6.115

4.  Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

Authors:  Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Hu-Liang Jia; Ping He; Krista A Zanetti; Udai S Kammula; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Cell       Date:  2006-08       Impact factor: 31.743

Review 5.  Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.

Authors:  Eric Van Cutsem; Bernard Nordlinger; Rene Adam; Claus-Henning Köhne; Carmelo Pozzo; Graeme Poston; Marc Ychou; Philippe Rougier
Journal:  Eur J Cancer       Date:  2006-08-10       Impact factor: 9.162

6.  Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus.

Authors:  T Utsunomiya; H Saitsu; M Saku; K Yoshida; T Matsumata; M Shimada; K Sugimachi
Journal:  Am J Surg       Date:  1999-04       Impact factor: 2.565

7.  Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.

Authors:  Christopher E Desch; Al B Benson; Mark R Somerfield; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; David G Pfister; Katherine S Virgo; Nicholas J Petrelli
Journal:  J Clin Oncol       Date:  2005-10-31       Impact factor: 44.544

Review 8.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

9.  Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.

Authors:  Steven R Alberts; William L Horvath; William C Sternfeld; Richard M Goldberg; Michelle R Mahoney; Shaker R Dakhil; Ralph Levitt; Kendrith Rowland; Suresh Nair; Daniel J Sargent; John H Donohue
Journal:  J Clin Oncol       Date:  2005-10-17       Impact factor: 44.544

Review 10.  Prevention and control of hepatitis B in China.

Authors:  Zongtang Sun; Lihua Ming; Xu Zhu; Jianhua Lu
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

View more
  20 in total

1.  Impact of Hepatitis B Carrier Status on the Outcomes of Surgical Treatment of Colorectal Liver Metastases.

Authors:  Kin Pan Au; Kenneth Siu Ho Chok; Albert Chi Yan Chan; Wing Chiu Dai; Tan To Cheung; Chung Mau Lo
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

2.  Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer.

Authors:  Koji Murono; Joji Kitayama; Nelson H Tsuno; Hiroaki Nozawa; Kazushige Kawai; Eiji Sunami; Masaaki Akahane; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2013-02-08       Impact factor: 2.571

3.  Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis.

Authors:  Bin Cai; Kai Liao; Xian-qing Song; Wei-yuan Wei; Yuan Zhuang; Sen Zhang
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

4.  Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Christos Dervenis; Evaghelos Xynos; George Sotiropoulos; Nikolaos Gouvas; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Evangelia Chrysou; Christos Emmanouilidis; Panagiotis Georgiou; Niki Karachaliou; Ourania Katopodi; Panteleimon Kountourakis; Ioannis Kyriazanos; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Paris Tekkis; Charina Triantopoulou; Maria Tzardi; Vassilis Vassiliou; Louiza Vini; Spyridon Xynogalos; Nikolaos Ziras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016-06-03

5.  Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.

Authors:  Qiwen Chen; Zhouyu Ning; Lei Wang; Haifeng Ying; Shu Dong; Chenyue Zhang; Xiaoheng Shen; Yuanbiao Guo; Hao Chen; Xiaoyan Zhu; Yehua Shen; Weidong Shi; Yongqiang Hua; Kun Wang; Junhua Lin; Litao Xu; Lianyu Chen; Lanyun Feng; Xiumei Zhang; Jing Xie; Bo Sun; Yaqin Sun; Wenchao Gu; Mei Kang; Zheng Tang; Zhujun Chen; Zhen Chen; Luming Liu; Jinming Yu; Zhaoshen Li; Zhiqiang Meng
Journal:  Oncotarget       Date:  2016-12-20

6.  Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis.

Authors:  Wu Jiang; Yu-Jing Fang; Xiao-Jun Wu; Fu-Long Wang; Zhen-Hai Lu; Rong-Xin Zhang; Pei-Rong Ding; Wen-Hua Fan; Zhi-Zhong Pan
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

7.  The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer.

Authors:  Xiao-li Wei; Miao-zhen Qiu; Wei-wei Chen; Ying Jin; Chao Ren; Feng Wang; Hui-yan Luo; Zhi-qiang Wang; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  J Transl Med       Date:  2013-10-08       Impact factor: 5.531

8.  FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION.

Authors:  Felipe José Fernandez Coimbra; Heber Salvador de Castro Ribeiro; Márcio Carmona Marques; Paulo Herman; Rubens Chojniak; Antonio Nocchi Kalil; Evanius Garcia Wiermann; Sandro Roberto de Araújo Cavallero; Fabricio Ferreira Coelho; Paulo Henrique de Souza Fernandes; Anderson Arantes Silvestrini; Maria Fernanda Arruda Almeida; Antônio Luis Eiras de Araújo; Marcos Pitombo; Heberton Medeiros Teixeira; Fábio Luiz Waechter; Fábio Gonçalves Ferreira; Alessandro Landskron Diniz; Giuseppe D'Ippolito; Giuseppe D'Ippolito; Maria Dirlei F de Sousa Begnami; Gabriel Prolla; Silvio Márcio Pegoraro Balzan; Thiago Bueno de Oliveira; Luís Arnaldo Szultan; Javier Lendoire; Orlando Jorge Martins Torres
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec

9.  Hepatitis B Virus Infection Predicts Better Survival In Patients With Colorectal Liver-only Metastases Undergoing Liver Resection.

Authors:  Yujie Zhao; Junzhong Lin; Jianhong Peng; Yuxiang Deng; Ruixia Zhao; Qiaoqi Sui; Zhenhai Lu; Desen Wan; Zhizhong Pan
Journal:  J Cancer       Date:  2018-04-12       Impact factor: 4.207

10.  Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation.

Authors:  Lipeng Cheng; Li Geng; Binghua Dai; Tao Zheng; Jun Fu; Liang Qiao; Wenchang Cai; Yue Wang; Jiamei Yang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.